Memorial Sloan Kettering Cancer Center: Lymphoma, Follicular trials

The registry lists 10 Lymphoma, Follicular studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 2 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 5Phase 2 5Phase 3 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Reduced Dose Radiation Therapy for People With B-Cell LymphomasRecruitingNCT07029217Phase 3
• A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaRecruitingNCT05389293Phase 2
• Study of the PD-L1 Inhibitor Atezolizumab With or Without Low-dose, Local Radiation in Patients With Relapsed or Refractory Advanced Stage Follicular LymphomaTerminatedNCT03465891Phase 2Results posted
• Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular LymphomaTerminatedNCT02282358Phase 1/2Results posted
• Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular LymphomaActive, not recruitingNCT04468841Phase 1
• AG-120 in People With IDH1 Mutant ChondrosarcomaActive, not recruitingNCT04278781Phase 2
• Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial ChemoimmunotherapyTerminatedNCT02966730Early Phase 1
• A Clinical Trial of Buparlisib and Ibrutinib in LymphomaCompletedNCT02756247Phase 1
• Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular LymphomaWithdrawnNCT01180569Phase 1/2
• PS-341 in Treating Patients With Hematologic CancerCompletedNCT00006098Phase 1